Model of Ubx activation refuted

For several years researchers thought that bithoraxoid noncoding RNAs (bxd ncRNAs) prevented the silencing of the Hox gene, Ultrabithorax, during Drosophila development. "If that's true, then the transcript for bxd should be expressed in the same cell as the transcript for Ubx," explains Faculty of 1000 member Pamela Geyer, a professor of Biochemistry at the University of Iowa. But recent experiments show that bxd transcripts aren't present in the same cells that expres Ubx transcripts.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

For several years researchers thought that bithoraxoid noncoding RNAs (bxd ncRNAs) prevented the silencing of the Hox gene, Ultrabithorax, during Drosophila development. "If that's true, then the transcript for bxd should be expressed in the same cell as the transcript for Ubx," explains Faculty of 1000 member Pamela Geyer, a professor of Biochemistry at the University of Iowa. But recent experiments show that bxd transcripts aren't present in the same cells that expres Ubx transcripts.1

The study, led by Alexander Mazo at Thomas Jefferson University in Philadelphia, used high-resolution, multiplex RNA in situ hybridization to illustrate differential expression of the genes. "This elegant method provided a simple answer," Geyer says.

The authors also show bxd appears to act in cis possibly through transcriptional interference, rather than through RNAi. They demonstrate that the Trithorax complex Tac1 associates with Ubx or bxd, whichever is being expressed.

Geyer says the data are convincing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies